Period 2 Suppresses the Malignant Cellular Behaviors of Colorectal Cancer Through the Epithelial-Mesenchymal Transformation Process.

Yubo XiongYifan ZhuangMengya ZhongWenjuan QinBoyi HuangJiabao ZhaoZhi GaoJingsong MaZhengxin WuXuehui HongZhicao YueHaijie Lu

Published in: Cancer control : journal of the Moffitt Cancer Center (2022)

In conclusion, low PER2 expression reinforces migration and activates EMT in CRC, suggesting that PER2 is closely related to CRC development and could be used as a potential treatment site in the clinic.

Keyphrases

poor prognosis
stem cells
bone marrow
epithelial mesenchymal transition
primary care
signaling pathway
long non coding rna
human health
combination therapy
climate change